NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Baymatob

Baymatob

Private
LeichhardtHealthcare & Life Scienceshttps://baymatob.com/

Last Round

Series A

Extension

May 26, 2026

Total Funding Raised

$14.48M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Baymatob is a medical device company developing an AI-powered maternal-fetal health platform designed to provide early warning for serious complications in pregnancy and labor.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Health IoT

Business Model

B2B

Customer Profile

Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

postpartum hemorrhagePPH predictionmaternal monitoringwearable medical deviceFemTechpredictive diagnosticsAI medical deviceMedTechwearable sensorfetal monitoringlabor and delivery monitoringclinical decision supportobstetrics technologyFDA breakthrough device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Baymatob Comps

Public and private peers based on sector, stage, and business model.

Baymatob comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Baymatob Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMay 26, 2026
GrantMay 5, 2026
GrantDec 23, 2024
Series A ExtensionMar 1, 2024
Series AMar 21, 2022
Grant
Aug 21, 2019

Baymatob Investors

Notable investors and investment history

Baymatob investors
InvestorRounds
Even CapitalSeries A Extension, Series A
Scale InvestorsSeries A Extension, Series A
NSW Medical Device FundGrant
ANDHealthGrant
Clare VenturesSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 17, 2026

    Monthly visitors grew 267% MoM, from 464 to 1.7K.

  • Feb 26, 2025

    Monthly visitors increased 358% MoM, reaching 5.5K.

Baymatob Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Baymatob Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Baymatob's valuation, stock price, and market status.

Firmographic Details

HeadquartersLeichhardt
Employee Range21
Year Founded2013
Last FundingMay 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.